• Provisional program

  •  
     
    ► Day 1: Tuesday 3rd Febr.
    MORNING SESSION (PRI Members Only)
    10:00–12:30 Yearly regulatory science roundup
    Key updates and perspectives on the evolving regulatory landscape
    12:30–13:30 Networking Lunch
    An opportunity to connect with fellow PRI members ahead of the main conference programme
    AFTERNOON | CONFERENCE KICK-OFF
      Session 1: Microbiome-based biomarkers; Microbiome testing and diagnostics
    14:00-17:00
    • Microbiome biomarkers in Europe: From expert consensus to regulatory implementation (Dr. Julie Rodriguez, PRI)
    • Bacterial markers and immune checkpoint inhibitors for oncology treatment (Dr. Lisa Derosa, Institut Gustave Roussy)
    • Managing chronic diseases through gut microbiome-derived biomarkers (Dr. Etienne Formstecher, GMT Science)
    • International consensus on microbiome testing in clinical practice (Dr. Gianluca Ianiro, Università Cattolica del Sacro Cuore, Rome)
    • Mapping microbial lineages: Analytical tools shaping the future of microbiome biomarkers (Dr. Nicola Segata, Principal Investigator at Department CIBIO, University of Trento)
    • Non-invasive diagnostics and the power of the vaginal microbiome: gynecological care and reproductive health (Dr. Marta Ciechońska, Salient Bio)
    • | Sponsor slot |
    Q&A session - Panel discussion  
    EVENING | WELCOME APÉRITIF & NETWORKING
     
     
    ► Day 2: Wednesday 4th Febr.
    MORNING
    Session 2: Microbiome innovation within the One Health concept, expanding microbiome application beyond human health
    09:00-12:45
    • Beyond Earth: Microbiome research for space missions and planetary health (Dr. Rodrigo Coutinho, European Space Agency)
    • Unexplored microbial diversity from food metagenomes
    • Plant-soil-gut microbiome intersections (Dr. Marc Ongena, Liege University)
    • Precision Probiotics for PFAS removal from the human body (Dr. Anna E. Lindell, Cambiotics)
    • Biocontrol or biostimulant? How classification shapes Innovation (Geoffroy Moulin, Staphyt)
    • From the ecology and functions of the plant microbiome to its importance in the foodsystem (Dr. Angela Sessitsch)
    • Roadmap for the integration of gastrointestinal (GI) microbiomes (human and domesticated animal) into risk assessments under EFSA ’s remit (Dr. F. Javier Moreno, Spanish National Research Council, CSIC)
    12:45-14:30 LUNCH BREAK, NETWORKING & POSTER SESSION
    AFTERNOON
    Session 3:  Microbiome in regulatory assessment and regulatory developments impacting microbiome R&D
    14:30-18:00
    • EFSA’s microbiome science initiative (Dr. Konstantinos Paraskevopoulos, EFSA)
    • Integrating environmental microbiome data into EFSA risk assessment (Dr. Frédéric Debode, Walloon Agricultural Research Centre)
    • SoHO Regulation and the Microbiome: What’s at stake, and where we go next (Dr. Céline Druart, PRI)
    • Implementing the SoHO Regulation: Technical guidance from HARMONIZE, EDQM & ECDC (Dr. Lena Biehl, Fraunhofer Institute for Translational Medicine and Pharmacology Frankfurt University of Cologne, Köln)
    • New SoHO regulation: EDQM guide on tissues and cells (Dr. Josbert Keller, Haaglanden Medical Center)
    • Regulatory Perspectives on the Non-Clinical Assessment of Microbiome-Based Medicinal Products (Dr. Violaine Francois, Non-clinical Assessor, Federal Agency for Medicines and Health Products)
    • SoHO Regulation in Practice: Updates on Implementation, GDPR and Clinical Trials (Stefaan Van der Spiegel, EC, DG Santé, Soho Head of Sector)
     
    2026 Featured session | Next Colony: Space.
    How can space boost microbiome-based innovation, and how can microbiome innovations drive space exploration? Join experts Dr. Christian Roghi and Dr. Pierre Burguière for an exclusive discussion on the intersection of microbiome science and space research.
    EVENING | Dinner at Wolf Sharing Food Market, Brussels city centre
     
     
    ► Day 3: Thursday 5th Febr.
    MORNING
    Session 4: Microbiome Innovation: Advances in Clinical Data & Emerging Technologies
    9:00-12:45
    • EXL01: A Novel single-strain live biotherapeutic for for macrophages modulation - Early clinical data and mechanism of action revealed (Benjamin Hadida, Exeliom Biosciences)
    • Precision microbiome medicines for immuno-oncology and inflammatory bowel disease (Dr. Adam Wilkinson, Microbiotica)
    • Synbiotics and infant colic: Clinical trial results (Professeur Yvan Vandenplas, UZ Brussel)
    • Harnessing GMO microbial strains to restore and support skin health (Dr. Maria Jose Fabrega, Synflora)
    • Precision sampling of the gut microbiome: clinical data from Nimble Science’s capsule technology (Dr. Sabina Bruehlmann, Nimble Science CEO)
    • Microbiome science as a tool for safer therapeutics and food: where are we in 2025? (David de Gruijl, Co-founder, Anto Biosciences)
    • Decoding Autism: Multi-Omics and AI insights into the gut-brain axis (Dr. Jamie Morton, Gutz Analytics)
    • Cognitive and mood benefits of multistrain Probiotics in healthy older adults: Evidence from a randomized controlled trial (Dr. Daniel Lamport, Associate Professor, School of Psychology & Clinical Language Sciences, University of Reading)
    • | Sponsor slot |
    Poster Session and Awards
    12:45-14:00 NETWORKING LUNCH (Onsite, takeaway options)
    14:00 | Conference ends
  • Event PlanneR
    Registration contact
    INSIGHT OUTSIDE
    26 av Jean Kuntzmann - 38330 Montbonnot, France
    Tel : +33 825 595 525 (0,15€/min*)
    Information desk: Monday to Friday
    from 9:00 to 12:00 and 14:00 to 17:00
    (*) Prices starting from fixed line incumbent, a surcharge may be applied by operators, counting the second after the first 45 seconds.

    According to France's Personal Data Privacy Act in effect since June 2004, you may send a request in writing to INSIGHT OUTSIDE 26 Avenue Jean Kuntzmann, 38330 - Montbonnot / France, or by email webmaster@insight-outside.fr to access your file in order to consult, modify and/or delete your personal information.

    © 2005 - 2025 Insight Outside